Consensus Cloud Solutions (CCSI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Q3 2024 revenue was $87.8 million, down 3.1% year-over-year, driven by a 13.6%-14% decline in SoHo revenue, partially offset by 5%-5.3% growth in Corporate revenue, which saw its fastest pace in six quarters.
Adjusted EBITDA was $46.9 million, down 1.2% year-over-year, with margin improving to 53.5% from 52.5% due to cost-saving measures.
Net income for Q3 2024 was $21.1 million, a 12% decrease from Q3 2023, impacted by a noncash foreign exchange revaluation loss and lower interest expense.
Corporate segment achieved record revenue and customer growth, while SoHo segment saw revenue and account declines.
Macroeconomic uncertainty, inflation, and higher interest rates continue to impact operations and customer acquisition.
Financial highlights
Q3 2024 consolidated revenue was $87.8 million, down 3.1% year-over-year, in line with expectations.
Adjusted EBITDA was $46.9 million, down 1.2% year-over-year, with margin at 53.5% (up 100 bps YoY).
Adjusted net income was $25.5 million, down 14.3% year-over-year, mainly due to a $5.8 million non-cash FX revaluation.
Adjusted EPS was $1.31, down 13.2% year-over-year; diluted EPS was $1.09.
Free cash flow for Q3 2024 was $33.6 million, down from $49.9 million in Q3 2023, mainly due to tax payment timing.
Outlook and guidance
Q4 2024 revenue guidance: $83M–$87M; adjusted EBITDA: $42M–$45M; adjusted EPS: $1.00–$1.24.
Full-year 2024 revenue guidance: $346M–$353M; adjusted EBITDA: $186M–$194M; adjusted EPS: $5.45–$5.55.
Q4 expected to have fewer business days, putting downward pressure on revenue.
Non-GAAP effective tax rate for Q4 2024 expected between 20.5% and 22.5%.
Management expects to fund operations, capex, and repurchases with existing cash and cash flow for at least the next 12 months.
Latest events from Consensus Cloud Solutions
- Corporate growth, record cash flow, and debt reduction drive a strong 2026 outlook.CCSI
Q4 202510 Feb 2026 - Healthcare solutions and recurring revenue drive growth as FY2024 guidance is reaffirmed.CCSI
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Net income and margins rose in Q2 2024 despite lower revenue, with improved guidance for the year.CCSI
Q2 20241 Feb 2026 - Healthcare interoperability, AI, and capital returns drive growth and margin improvement.CCSI
Jefferies Global Healthcare Conference31 Jan 2026 - Record free cash flow, margin strength, and debt reduction highlight 2024 performance.CCSI
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and strong governance.CCSI
Proxy Filing2 Dec 2025 - Virtual meeting to vote on directors, auditor, and executive pay, all board-recommended.CCSI
Proxy Filing2 Dec 2025 - Q1 2025 revenue down 1.1%, Corporate growth offsets SoHo decline; guidance reaffirmed.CCSI
Q1 202525 Nov 2025 - Corporate revenue up 6.9% year-over-year, driving first total revenue growth in eight quarters.CCSI
Q2 202523 Nov 2025